Molecular changes in carbohydrate antigens associated with cancer

BioEssays

Volumn 12, Issue 5, 1990, Pages 223-230

  Singhal, Anil ^a   Hakomori, Sen‐Itiroh ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; OLIGOSACCHARIDE; TUMOR ANTIGEN;

ANIMAL; CARBOHYDRATE ANALYSIS; CELL TRANSFORMATION; GENETICS; GLYCOSYLATION; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; REVIEW;

ANIMAL; ANTIGENS, NEOPLASM; CARBOHYDRATE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; EPITOPES; GLYCOSYLATION; HUMAN; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES;

EID: 0025423331     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.950120506     Document Type: Review

References (48)

1. Glycoconjugate expression during embryogenesis and its biological significance
2. Isolation of glycolipid containing fucose, galactose, glucose, and glucosamine from human cancerous tissue
3. A sphingolipid having a novel type of ceramide and lacto‐ N‐fucopentaose III
4. b‐glycolipids in human tumor tissue
5. Association of the glycolipid pattern with antigenic alterations in mouse fibroblasts transformed by murine sarcoma virus
6. Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor‐associated α‐ N‐acetylgalactosaminyl epitope) that does not cross‐react with blood group A antigen
7. Preparation and characterization of monoclonal antibodies directed to the tumor‐associated O‐linked sialosyl‐2→6 α‐ N‐acetylgalactosaminyl (sialosyl‐Tn) epitope
8. Monoclonal antibodies and synthetic tumor‐associated glycoconjugates in the study of the expression of Thomsen‐Friedenreich‐like and Tn‐like antigens on human cancers
9. Characterization of a human melanoma‐associated ganglioside antigen defined by a monoclonal antibody, 4.2
10. Ganglioside GM2 as a human tumor antigen (OFA‐I‐1)
11. 2
12. 3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins
13. Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody
14. 4) of human adenocarcinoma and the monoclonal antibody (FH9) defining this disialosyl structure
15. Colorectal carcinoma antigens detected by hybridoma antibodies
16. Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed β1→3N‐acetylglucosaminyltransferase
17. Monoclonal antibody defining a stage‐specific mouse embryonic antigen (SSEA‐1)
18. Novel fucolipids accumulating in human adenocarcinoma: II. Selective isolation of hybridoma antibodies that differentially recognize mono‐, di‐, and trifucosylated type 2 chain
19. Localization and alteration of mono‐, di‐, and trifucosylα1→3 type 2 chain structures during human embryogenesis and in human cancer
20. y) defined by monoclonalantibody AH6 in different locations of colonic epithelia, various histologic types of colonic polyps, and adenocarcinomas
21. y blood group‐related antigens in human malignant, premalignant, and nonmalignant colonic tissues
22. 6)
23. A‐like blood group antigen in gastric cancer cells of patients in blood groups O and B
24. Incompatible A antigen expressed in tumors of blood group O and B individuals: Immunochemical, immunohistologic, and enzymatic characterization
25. Enzymatic and organizational difference in expression of a Burkitt lymphoma‐associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines
26. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage‐specific embryonic antigen 3
27. Recognition of galactosylgloboside by monoclonal antibodies derived from patients with primary lung cancer
28. d3 ganglioside: A phase I trial in patients with malignant melanoma
29. 3 lactone as a possible immunogen: Requirements for tumorassociated antigen and immunogen
30. Characterization of tumor‐associated ganglio‐ N‐triaosylceramide in mouse lymphoma and the dependence of its exposure and antigenicity on the sialosyl residues of a second glycoconjugate
31. Differential reactivities of fetal and adult human erythrocytes to antisera directed against glycolipids of human erythrocytes
32. Glycolipid markers of murine lymphocyte subpopulations
33. Monoclonal antibody specific for lactosylceramide (LacCer)
34. Monoclonal antibody detection of a circulating tumor‐associated antigen: I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma
35. Quantitative and qualitative characterization of human cancer‐associated serum glycoprotein antigens expressing fucosyl of sialyl‐fucosyl type 2 chain polylactosamine
36. Detection of patients with cancer by monoclonal antibody directed to lactoneotetraosylceramide (paragloboside)
37. x‐ containing glycoproteins and glycolipids in sera of patients with adenocarcinoma
38. Gangliosides in serum immune complexes from tumor‐bearing patients
39. x) in the circulating immune complexes of patients with adenocarcinoma
40. Localization of GD2‐specific monoclonal antibody 3F8 in human osteosarcoma
41. Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: Selection of low antigenic variants in vivo
42. d3‐ganglioside antibody
43. Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3
44. Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2
45. Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72. 3: Histological and autoradiographic study of effects on tumors and normal organs
46. Antibody‐mediated targeting of differentiation inducers to tumor cells: Inhibition of colonic cancer cell growth in vitro and in vivo: A preliminary note
47. T cell recognition of a tumor‐associated glycoprotein and its synthetic carbohydrate epitopes: Stimulation of anticancer T cell immunity in vivo. Cancer Immunol
48. Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients